
Dolby Laboratories (DLB) Stock Forecast & Price Target
Dolby Laboratories (DLB) Analyst Ratings
Bulls say
Dolby Laboratories Inc. has reported a 1.6% year-over-year increase in its product and services segment, with growth surpassing the company's initial forecasts due to favorable deal timing. The company's licensing revenue, which constitutes nearly half of its total earnings, is poised for further growth through the adoption of its technologies, driven by strong demand for platforms like Atmos, Vision, and the Imaging Patents. Additionally, Dolby is strategically expanding its revenue model to include SaaS-like solutions linked to patent licensing, providing further potential for robust revenue growth moving forward.
Bears say
Dolby Laboratories is projecting a significant decline in revenue, with a model indicating a 7.5% year-over-year decrease in licensing revenue and a 5.7% drop in products and services for the December quarter. The company is also facing increased operating expenses, contributing to an overall anticipated high-single-digit revenue decline for fiscal 2026, mirroring the declining trends observed in fiscal 2025. Additionally, the gross margins have decreased from 90.8% to 89.8%, reflecting pressures in product and service margins, which further exacerbates the negative financial outlook for Dolby Laboratories.
This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.
Dolby Laboratories (DLB) Analyst Forecast & Price Prediction
Start investing in Dolby Laboratories (DLB)
Order type
Buy in
Order amount
Est. shares
0 shares